Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-13

Clinical Trial Update: Patient-Reported Outcome Of Facial Erythema (PROOF) [Phase 3]

View source ↗

Summary

Phase 3 trial update for the Patient-Reported Outcome of Facial Erythema (PROOF) in rosacea with erythema; results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Galderma R&D | Conditions: Rosacea, Erythema | Phase 3 | Status: COMPLETED | Results posted: 2017-01-13